학술논문
Genetic findings in a patient with paradoxical pyoderma gangrenosum induced by brodalumab.
Document Type
Article
Author
Source
Subject
*PYODERMA gangrenosum
*MONONUCLEAR leukocytes
*JUVENILE idiopathic arthritis
*
*
Language
ISSN
0307-6938
Abstract
CPD questions Learning objective To gain up-to-date knowledge about the pathogenesis of pyoderma gangrenosum and the relationship between treatment with brodalumab and pyoderma gangrenosum. Pyoderma gangrenosum (PG) is a rare inflammatory skin disease classified within the group of neutrophilic dermatoses. [Extracted from the article]